I. 21 Red Onion
The quercetin-concentrate onion variant – anthocyanin bonus + powerful cardiovascular polyphenol matrix.
Red Onion in 1 minute
What does it provide? Compared with the classic yellow onion (I.5), 2–5× higher quercetin content (40–100 mg/100 g) and an anthocyanin concentrate (cyanidin-3-glucoside 50–150 mg/100 g) in the red outer skin and flesh. The fructan-prebiotic fraction (FOS) is identical to the yellow onion.
How much? ½–1 bulb (≈ 50–100 g) raw or roasted/day. Quercetin RCTs (Brüll 2015 Br J Nutr) used a daily dose of 162 mg, which a single red onion sufficiently covers [2755].
When to avoid? IBS elimination phase (high FODMAP – fructan). Warfarin therapy (allicin-mediated weak anticoagulant potential). Allium allergy (rare).
The red onion varieties (Tropea, Cipollini, Red Wing) emerged through natural mutation in the 16th-century Italian region of Calabria – a variant of the MYB gene regulating anthocyanin synthesis produced the red-purple color. In Renaissance Italy, "cipolla rossa" was chosen over white onions for its prized characterful flavor. In modern quercetin literature, Brüll 2015 Br J Nutr RCT placed the red onion as a recognized clinical blood-pressure-lowering ingredient.
Scientific Background
The red onion's main bioactive difference from the yellow onion (I.5) is its quercetin and anthocyanin concentration. Quercetin content is 40–100 mg/100 g – 2–5× that of the yellow onion [2757] [2758]. Systemic quercetin bioavailability is low (5–10%), but the colonic microbiome converts it into protocatechuic acid and other phenolic acids, and these metabolites improve endothelial function [2760].
Brüll 2015 Br J Nutr randomized, double-blind, crossover RCT showed that 162 mg/day quercetin (≈ 1 red onion or equivalent capsule) significantly reduced 24-hour ambulatory systolic blood pressure (≈ −2.6 mmHg) over 6 weeks [2755]. Edwards 2007 J Nutr showed LDL reduction with a similar protocol [1294].
The anthocyanin fraction (concentrated in the red skin) provides an Akkermansia-Bifidobacterium-supporting polyphenol matrix – analogous to the anthocyanin effect of elderberry and red cabbage. The evidence is based on small human pilots and in vitro fermentation studies.
The fructan-prebiotic fraction is identical to the yellow onion – bifidogenic, but red (Monash category) for FODMAP-sensitive individuals [2759].
- + Extra-virgin olive oil + tomato: classic "sofrito" + red onion = polyphenol stack.
- + Balsamic vinegar: acid + anthocyanin color stabilization + glycemic control.
- + Roasted meat (beef, chicken): classic "red onion gravy."
- + Avocado + lime: Mexican "salsa" matrix.
- + Fermented dairy (yogurt, kefir): quercetin + LAB synbiotic.
- + In a raw salad matrix: maximum quercetin preservation.
- Very long boiling (> 30 min): quercetin loss 40–60%; brief sauté or raw preferred.
- Milk consumed directly with raw red onion: GI discomfort varies individually.
- GERD flare: raw consumption may aggravate.
- IBS elimination phase: high FODMAP – avoid in the first 4–6 weeks.
- Warfarin therapy: dietary amount is safe; high-dose quercetin supplement to be avoided.
- Allium allergy: complete avoidance.
- Infants under 8 months: avoid (as with all alliums).
- GERD: raw to be avoided, roasted/sautéed OK.
References
[1294] Edwards RL et al. Quercetin reduces blood pressure in hypertensive subjects2007;137(11):2405–2411. J Nutr. 2007. Link
Epidemiological studies report that quercetin, an antioxidant flavonol found in apples, berries, and onions, is associated with reduced risk of coronary heart disease and stroke. Quercetin supplementation also reduces blood pressure in hypertensive rodents. The efficacy of quercetin supplementation to lower blood pressure in hypertensive humans has never been evaluated. We tested the hypothesis that quercetin supplementation reduces blood pressure in hypertensive patients. We then determined whether the antihypertensive effect of quercetin is associated with reductions in systemic oxidant stress. Men and women with prehypertension (n = 19) and stage 1 hypertension (n = 22) were enrolled in a randomized, double-blind, placebo-controlled, crossover study to test the efficacy of 730 mg quercetin/d for 28 d vs. placebo.
[2755] Brüll V, Burak C, Stoffel-Wagner B, Wolffram S, Nickenig G, Müller C et al. Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial. British Journal of Nutrition. 2015. Link
Randomized, double-blind, crossover, placebo-controlled RCT examining the effect of a quercetin-rich onion skin extract on 24-hour ambulatory blood pressure in (pre-)hypertensive, overweight patients. A daily 162 mg quercetin dose significantly reduced systolic blood pressure over 6 weeks.
[2757] Lee J, Mitchell AE. Quercetin and isorhamnetin glycosides in onion (Allium cepa L.): varietal comparison, physical distribution, coproduct evaluation, and long-term storage stability. Journal of Agricultural and Food Chemistry. 2011. Link
Study of the quercetin and isorhamnetin glycoside content of onion (Allium cepa), with varietal comparison and physical distribution of the compounds. It documents the higher quercetin concentration of red onion relative to yellow onion.
[2758] . Onion, red, raw (NDB 170006). USDA FoodData Central. 2019. Link
Entry from the USDA FoodData Central nutrition database for raw red onion, documenting macro- and micronutrient composition. A reference source for the context of the quercetin and anthocyanin values reported in the chapter.
[2759] . Onion, red — low FODMAP serving guidance. Monash University FODMAP. 2023. Link
Classification from the Monash University FODMAP database placing red onion — like yellow onion — in the high-FODMAP (fructan) category. It provides a practical basis for avoidance during the IBS elimination phase.
[2760] Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. European Journal of Pharmacology. 2008. Link
Review of the health effects of quercetin, from antioxidant role to nutraceutical application. It summarizes the low systemic bioavailability of quercetin and the formation of phenolic-acid metabolites by the gut microbiome.

